TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
Home›QCRH›Financials
Annual statements · SEC XBRL · FY2016 – FY2025

QCR HOLDINGS INC (QCRH) financials

Income statement

QCR HOLDINGS INC (QCRH) income statement, annual, from SEC filings
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$138M$166M$224M$295M$312M$301M$373M$546M——
Revenue growth—20.7%35.2%31.4%5.9%-3.7%24.2%46.3%——
Net income$27.7M$35.7M$43.1M$57.4M$60.6M$98.9M$99.1M$114M$114M$127M
Net margin20.1%21.5%19.2%19.5%19.4%32.9%26.5%20.8%——
EPS (diluted)$2.17$2.61$2.86$3.60$3.80$6.20$5.87$6.73$6.71$7.49

Cash flow

QCR HOLDINGS INC (QCRH) cash flow, annual, from SEC filings
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$43.4M$33.7M$64.3M$76.5M$112M$88.2M$119M$376M$445M$422M
Capital expenditures$6.03M$5.76M$11.5M$12.4M$4.27M$14.0M$33.3M$14.9M$44.5M$67.4M
Free cash flow$37.4M$28.0M$52.8M$64.1M$108M$74.2M$85.4M$361M$400M$354M

Balance sheet

QCR HOLDINGS INC (QCRH) balance sheet, annual, from SEC filings
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$70.6M$75.7M$85.5M———————
Total assets$3.30B$3.98B$4.95B$4.91B$5.71B$6.10B$7.95B$8.54B$9.03B$9.58B
Total liabilities$3.02B$3.63B$4.48B$4.37B$5.11B$5.42B$7.18B$7.65B$8.03B$8.46B
Shareholders' equity$286M$353M$473M$535M$594M$677M$773M$887M$997M$1.11B
Retained earnings$119M$152M$192M$246M$301M$386M$450M$555M$665M$773M
Shares (wtd avg diluted)12.8M13.7M15.1M16.0M16.0M15.9M16.9M16.9M17.0M17.0M

Every figure is extracted from QCR HOLDINGS INC’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.

Common questions

What is QCR HOLDINGS INC's free cash flow?
$354M in FY2025 (operating cash flow $422M minus $67.4M of capital expenditures), from the SEC cash-flow statement.
Does QCRH pay a dividend?
QCR HOLDINGS INC reported no cash dividends paid in FY2025, per its SEC cash-flow statement.
Full QCRH analysis — verdict, score & filings →Is QCRH a buy? →

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.